Experimental effects of Saccharomyces boulardii on diarrheal pathogens (Q34688679)

3 August 2017

1 reference

title

Experimental effects of Saccharomyces boulardii on diarrheal pathogens (English)

1 reference

3 August 2017

main subject

Saccharomyces boulardii

object named as

Saccharomyces boulardii

1 reference

Dorota Czerucka

1

1 reference

3 August 2017

Patrick Rampal

series ordinal

2

1 reference

3 August 2017

publication date

1 June 2002

1 reference

3 August 2017

published in

Microbes and Infection

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

733-739

1 reference

Probiotics in human medicine

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Protection from gastrointestinal diseases with the use of probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Biotherapeutic agents in the treatment of infectious diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Electrophoretic karyotypes of authentic strains of the sensu stricto group of the genus Saccharomyces

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Disposition kinetics of Saccharomyces boulardii in man and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Micro-organisms administered in the benefit of the host: myths and facts

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Possible role of catheters in Saccharomyces boulardii fungemia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Enteropathogenic and enterohaemorrhagic Escherichia coli : more subversive elements

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901592-7

7 January 2021

10.1016/S1286-4579(02)01592-7

Identifiers

DOI

1 reference

3 August 2017

1 reference